U.S. federal trademark · Serial No. 79057962 · Reg. No. 3587471
Medical and scientific research, namely, conducting clinical trials and studies to explore the effect of two different blood glucose targets and to affect glucose control in patients with type 2 diabetes using insulin detemir once daily in combination with agents for oral administration
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.